In the version of this article initially published, it was reported that deCODE had "shuttered its Emerald Biosciences and Emerald Biostructures drug discovery operations"; in fact, the companies were sold to investors. In addition, the correct name of Emerald Biosciences is Emerald BioSystems. The error has been corrected in the HTML and PDF versions of the article. In the version of the article originally published, Michael Tolentino was misquoted to the effect that bevasiranib had been shown to persist indefinitely in post-mitotic cells. Tolentino actually stated that the RNA-induced signaling complex persists. The error has been corrected in the HMTL and PDF versions of the article. e r r ata
